scholarly article | Q13442814 |
P50 | author | Diego Arango | Q38642741 |
P2093 | author name string | Leonard H Augenlicht | |
Dineo Khabele | |||
Gary L Goldberg | |||
Susan J Gross | |||
Melissa Lopez-Jones | |||
WanCai Yang | |||
P2860 | cites work | Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice | Q24616207 |
Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
Transcription initiation sites and promoter structure of the human TRAIL-R3 gene | Q28213507 | ||
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors | Q28245164 | ||
Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines | Q28344057 | ||
Use of a cDNA microarray to analyse gene expression patterns in human cancer | Q29618814 | ||
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer | Q34652960 | ||
Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis | Q36012041 | ||
Potential role of p53 on metallothionein induction in human epithelial breast cancer cells | Q36624370 | ||
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes | Q37372150 | ||
Metallothionein in carcinogenesis and cancer chemotherapy. | Q38302990 | ||
Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB. | Q39681517 | ||
Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron | Q40016658 | ||
A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer | Q40666631 | ||
Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends | Q40704208 | ||
c-Myc augments the apoptotic activity of cytosolic death receptor signaling proteins by engaging the mitochondrial apoptotic pathway | Q40707744 | ||
The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells | Q43680631 | ||
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy | Q44023471 | ||
Zinc-metallothionein protects from DNA damage induced by radiation better than glutathione and copper- or cadmium-metallothioneins | Q44264796 | ||
PIK3CA is implicated as an oncogene in ovarian cancer. | Q46015944 | ||
Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)). | Q52196656 | ||
Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations. | Q53394047 | ||
Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways | Q57267084 | ||
Drug target validation and identification of secondary drug target effects using DNA microarrays | Q77534975 | ||
Expression of transcriptional repressor ATF3/LRF1 in human atherosclerosis: colocalization and possible involvement in cell death of vascular endothelial cells | Q77752977 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 19-26 | |
P577 | publication date | 2004-04-01 | |
P1433 | published in | Gynecologic Oncology | Q5625182 |
P1476 | title | Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer | |
P478 | volume | 93 |
Q39293860 | Effect of epothilone B on cell cycle, metabolic activity, and apoptosis induction on human epithelial cancer cells-under special attention of combined treatment with ionizing radiation |
Q37224303 | Gene-expression profiling in epithelial ovarian cancer |
Q33719525 | The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21 |
Search more.